ASPATRIA MEDICAL GROUP
WEST STREET, ASPATRIA, WIGTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 9 | 15 | 60.0% | |
| HF 4 | 2011 | 11 | 15 | 73.3% | |
| HF 4 | 2012 | 18 | 24 | 75.0% | |
| HF 4 | 2013 | 31 | 36 | 86.1% | |
| HF004 | 2014 | 19 | 20 | 95.0% | |
| HF004 | 2015 | 23 | 24 | 95.8% | |
| HF004 | 2016 | 20 | 21 | 95.2% | |
| HF004 | 2017 | 41 | 45 | 91.1% | |
| HF004 | 2018 | 42 | 47 | 89.4% | |
| HF004 | 2019 | 40 | 43 | 93.0% | |
| HF004 | 2020 | 39 | 42 | 92.9% | |
| HF006 | 2021 | 33 | 39 | 84.6% | |
| HF006 | 2022 | 32 | 34 | 94.1% | |
| HF006 | 2023 | 36 | 36 | 100.0% |
